Abstract
Renal cell carcinoma (RCC) represents the third urologic neoplasm in frequency, its prognosis is poor in an advanced stage and early detection is difficult due to the lack of molecular biomarkers. Researchers are devoted to earlier detection of RCC and rising life expectancy of cancer survivors. What’s more, the understanding of RCC was improved since the development and the application of the molecular biology experimental technique, including the pathogenesis and etiology, RCC subtypes and prognostic factors of RCC. The goal of this review is to overview the research advances in RCC. Key words: Renal cell carcinoma; Pathogenesis; Prognosis
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
